NCT05704478View on ClinicalTrials.gov

Impact of Vericiguat on Hemodynamics of Heart Failure

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Heart Failure
Interventions
DRUG

Vericiguat

soluble guanylate cyclase stimulator

All Listed Sponsors
lead

University of Colorado, Denver

OTHER